Paper · 3907235
Glycemic control with an artificial pancreas improves insulin responses to both oral and glucose in nonobese noninsulin-dependent diabetic subjects.
Giugliano D and 6 others. Acta Diabetol Lat, 1985. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glycemic control with an artificial pancreas improves insulin responses to both oral and glucose in nonobese noninsulin-dependent diabetic subjects. Papers, record 3907235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3907235
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glycemic control with an artificial pancreas improves insulin responses to both oral and glucose in nonobese noninsulin-dependent diabetic subjects.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Glucose | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Glucose Tolerance Test | Major topic |
| Insulin | Major topic |
| Insulin Infusion Systems | Major topic |
| Administration, Oral | |
| Adult | |
| C-Peptide | |
| Fasting | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Middle Aged |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 447,800 | Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/447800 | PubMed |
| 2 | 3,882,489 | The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. | Diabetes | 1985 | https://conductscience.org/library/papers/3882489 | PubMed |
| 3 | 1,268,654 | Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. | Br Med J | 1976 | https://conductscience.org/library/papers/1268654 | PubMed |
| 4 | 447,806 | Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/447806 | PubMed |
| 5 | 154,427 | Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes. | Diabetes | 1979 | https://conductscience.org/library/papers/154427 | PubMed |
| 6 | 7,043,166 | The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. | Metabolism | 1982 | https://conductscience.org/library/papers/7043166 | PubMed |
| 7 | 783,201 | Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. | J Clin Invest | 1976 | https://conductscience.org/library/papers/783201 | PubMed |
| 8 | 7,019,230 | Calcitonin, a diabetogenic hormone? | J Clin Endocrinol Metab | 1981 | https://conductscience.org/library/papers/7019230 | PubMed |
| 9 | 7,033,272 | Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. | J Clin Endocrinol Metab | 1982 | https://conductscience.org/library/papers/7033272 | PubMed |
| 10 | 755,038 | Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics. | J Clin Endocrinol Metab | 1978 | https://conductscience.org/library/papers/755038 | PubMed |
1 to 10 of 26
See all 26 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 1,644,911 | Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1644911 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3907235
GET https://conductscience.org/api/papers/v1/3907235/references?page=2